ArticleFEBS open bio2024
Retraction: IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling.
Article in FEBS open bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling. Jiaqi Min, Qian Feng, Wenjun Liao, Yiming Liang, Chengwu Gong, Enliang Li, Wenfeng He, Rongfa Yuan, Linquan Wu, FEBS Open Bio, 8: 1299-1311. https://doi.org/10.1002/2211-5463.12479 The above article, published online on 14 June 2018 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief Miguel De la Rosa, the corresponding author, FEBS Press, and John Wiley and Sons Ltd. The retraction has been agreed due to the identification of duplication and repositioning of images in Figs 2C-E and 3C,D and excessive editing (high contrast) of Western blot images throughout the article. The authors were unable to provide the original raw Western blot data upon request. Given the extent of the identified issues, the editors have lost confidence in the data presented and have therefore decided to retract it.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.